Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Nucl Med ; 49(1): e8-e9, 2024 Jan 01.
Article in English | MEDLINE | ID: mdl-37991439

ABSTRACT

ABSTRACT: We present isolated bilateral adrenal metastases successfully treated with 177 Lu-PSMA in a 66-year-old man diagnosed with castration-resistant prostate cancer. The patient had progression under chemotherapy as depicted by 68 Ga-PSMA PET/CT showing intense bilateral PSMA uptake in the adrenal masses, and metastasis-directed therapies were considered as the first option for improving survival because the patient was oligometastatic. However, surgery and radiotherapy were not justifiable options due to the high risk of definitive adrenal insufficiency; therefore, the patient received 4 cycles of 177 Lu-PSMA treatment. 68 Ga-PSMA PET/CT showed near-complete response in bilateral adrenal metastases, and no sign of adrenal insufficiency was observed during follow-up.


Subject(s)
Adrenal Insufficiency , Prostatic Neoplasms, Castration-Resistant , Male , Humans , Aged , Positron Emission Tomography Computed Tomography , Prostatic Neoplasms, Castration-Resistant/pathology , Treatment Outcome , Radiopharmaceuticals/therapeutic use , Prostate-Specific Antigen , Dipeptides/therapeutic use , Adrenal Insufficiency/drug therapy , Heterocyclic Compounds, 1-Ring/therapeutic use , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...